Direktorat Registrasi ObatValid

CARDIOTONE

Claim this product
BPOM Number
DKL1104000343A1
Approved
30 March 2026
Expiry
2 January 2031
Form
INJEKSI

About This Registration

CARDIOTONE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL1104000343A1. Its current registration status is Valid, with the licence valid until 2 January 2031. The product is registered to PRIMA MEDIKA LABORATORIES - INDONESIA. BPOM first approved this registration in January 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 1 AMPUL @ 5 ML
Department
Direktorat Registrasi Obat
Data Last Updated
13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

DOBUTAMINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio
PRIMA MEDIKA LABORATORIES - INDONESIA holds 75 BPOM registrations
Manufacturer Scale
PRIMA MEDIKA LABORATORIES - INDONESIA produces 75 registered products
Registration Age
Registered for 6 months

FDA Cross-Reference

via openFDA
Generic Name
ADENOSINUM TRIPHOSPHORICUM DINATRUM, CACTUS GRANDIFLORUS, CONVALLARIA MAJALIS, HEART (SUIS), MAGNESIUM GLUCONATE, POTASSIUM GLUCONATE, THYROIDINUM (SUIS), UBIDECARENONUM, GERMANIUM SESQUIOXIDE, STROPHANTHUS HISPIDUS, ADONIS VERNALIS, DIGITALIS PURPUREA
Product Type
HUMAN OTC DRUG
Route of Administration
ORAL
Purpose
INDICATIONS: For temporary relief of difficulty breathing after walking, tiredness, feeling as if you can't breathe, and profuse perspiration.

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1